Becton Dickinson (BDX) announced the launch of the BD Pyxis Pro Dispensing Solution and BD Incada Connected Care Platform in Europe. This next-generation medication dispensing system combines advanced automation and AI-driven insights to modernize medication management, reduce disruptions, and improve efficiency while helping clinicians spend more time on patient care.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- Becton Dickinson price target lowered to $180 from $230 at Argus
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
- Becton Dickinson receives FDA clearance for Surgiphor 1000mL
- Becton Dickinson Expands Debt Tender Offers Amid Strong Demand
- Fourteen new option listings and one option delisting on February 11th